BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

July 24, 2020 Leave a comment 992 Views

BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NurOwn®

BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

UTMB team proves potential for reducing pre-term birth by treating fetus with bioengineered exosomes

Exosomes targeted towards applications in regenerative medicine

Research in extracellular vesicles earns Young Investigator Award

New publication details the characterization of novel scaffold proteins that can enable engineered exosomes with defined therapeutic properties

MSC extracellular vesicle therapy developed at Boston Children’s stops preeclampsia before it starts

The microfluidic toolbox for analyzing exosome biomarkers